Clinical Trial Update: Effect of Risk Factors Likely to Influence Immuno of Combined Hepatitis A & B Vacc vs Monovalent Hepatitis A & B Vacc [Phase 4]

View source ↗

Summary

Phase 4 clinical trial evaluating factors influencing immune response to combined Hepatitis A & B vaccine vs monovalent vaccines; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis A
• Hepatitis B

Drugs mentioned

• GlaxoSmithKline Hepatitis A & B vaccine (combined)
• Hepatitis A vaccine (inactivated Hepatitis A vaccine)
• Hepatitis B vaccine (Hepatitis B vaccine)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Hepatitis B, Hepatitis A | Phase 4 | Status: COMPLETED | Results posted: 2018-10-03